01 2Zhejiang Shenzhou Pharmaceutical Co. , Ltd.
01 1Canrenoate potassium
02 1Potassium Canrenoate
01 2China
Registration Number : 219MF10376
Registrant's Address : No. 14 Chuangcheng Nan Road 317300, Xianju, Zhejiang, China
Initial Date of Registration : 2007-12-19
Latest Date of Registration : 2007-12-19
Registration Number : 302MF10059
Registrant's Address : No. 14 Chuangcheng Nan Road 317300, Xianju, Zhejiang, China
Initial Date of Registration : 2020-05-25
Latest Date of Registration : 2020-05-25
A Canrenoate Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Canrenoate Potassium, including repackagers and relabelers. The FDA regulates Canrenoate Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Canrenoate Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Canrenoate Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Canrenoate Potassium supplier is an individual or a company that provides Canrenoate Potassium active pharmaceutical ingredient (API) or Canrenoate Potassium finished formulations upon request. The Canrenoate Potassium suppliers may include Canrenoate Potassium API manufacturers, exporters, distributors and traders.
click here to find a list of Canrenoate Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Canrenoate Potassium Drug Master File in Japan (Canrenoate Potassium JDMF) empowers Canrenoate Potassium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Canrenoate Potassium JDMF during the approval evaluation for pharmaceutical products. At the time of Canrenoate Potassium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Canrenoate Potassium suppliers with JDMF on PharmaCompass.
We have 1 companies offering Canrenoate Potassium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
